Skip to content
★ Sign in to follow
LG

Laurie Glimcher

Board Director
GlaxoSmithKline plc
Total declarations
17
Company
1
▲ Purchases (1 ops.)
€45k
▼ Sales (0 ops.)
—

Latest filing published 22 Sept 2021 for GlaxoSmithKline plc, €35k.

Filing timeline

BuySale
Laurie Glimcher

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Laurie Glimcher: trading record in brief

All filings by Laurie Glimcher on record concern GlaxoSmithKline plc. Over a trading history stretching from 25 October 2017 to 20 September 2021, the count stands at 17 filings.

On the market, this insider has only ever bought: 1 purchase, €45k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 16 share grants.

Most recently, on 22 September 2021, the filings show a share grant worth €35k in GlaxoSmithKline plc. The clock since the last published purchase (26 April 2018) now reads 3,119 days. The median gap between trade and publication is zero days: most filings appear on the same day. The regulation allows three business days to notify a trade (UK MAR). Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Laurie Glimcher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    41,309 USD0FCA-NSM
    1,056.776 shares@ US$39.09N/AISIN US37733W1053FCA-NSM:4118924-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    41,309 USD0FCA-NSM
    1,049.794 shares@ US$39.35N/AISIN US37733W1053FCA-NSM:4078201-6
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    41,309 USD0FCA-NSM
    1,094.288 shares@ US$37.75N/AISIN US37733W1053FCA-NSM:3958103-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    40,241 USD0FCA-NSM
    1,076.24 shares@ US$37.39N/AISIN US37733W1053FCA-NSM:3868580-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    40,241 USD0FCA-NSM
    1,140.284 shares@ US$35.29N/AISIN US37733W1053FCA-NSM:3762711-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    49,898 USD15FCA-NSM
    1,222.4 shares@ US$40.82100.0% of flowN/AISIN US37733W1053FCA-NSM:3671412-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    49,898 USD0FCA-NSM
    1,176.571 shares@ US$42.41N/AISIN US37733W1053FCA-NSM:3585138-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD12FCA-NSM
    1,172.635 shares@ US$46.8854.0% of flowN/AISIN US37733W1053FCA-NSM:LSE20200205161501_3485422_20200331164939523_4518-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD8FCA-NSM
    1,241.769 shares@ US$44.2710.2% of flown/aISIN US37733W1053FCA-NSM:LSE20191030173245_14287547_20200326185152081_1913-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD8FCA-NSM
    1,336.245 shares@ US$41.1410.2% of flown/aISIN US37733W1053FCA-NSM:LSE20190724180132_14162079_20200326185123368_9582-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD9FCA-NSM
    1,351.687 shares@ US$40.6717.5% of flown/aISIN US37733W1053FCA-NSM:LSE20190501151148_14059820_20200326185143207_28739-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD9FCA-NSM
    1,399.876 shares@ US$39.2717.2% of flown/aISIN US37733W1053FCA-NSM:LSE20190206122044_13960527_20200326185112577_23728-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD8FCA-NSM
    1,394.549 shares@ US$39.4212.5% of flown/aISIN US37733W1053FCA-NSM:LSE20181102161501_13853842_20200330111439106_28101-4
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD9FCA-NSM
    1,329.78 shares@ US$41.3416.7% of flown/aISIN US37733W1053FCA-NSM:LSE20180725161500_13731434_20200330111420045_5006-4
  • ▲
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD23FCA-NSM
    1,363.083 shares@ US$40.3313.4% of flown/aISIN US37733W1053FCA-NSM:LSE20180426153013_13620557_20200330111351383_2832-5
    Canonical exit: 24 Jul 2018 (T+90)
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    54,973 USD9FCA-NSM
    1,518.595 shares@ US$36.2015.2% of flown/aISIN US37733W1053FCA-NSM:LSE20180207131918_13525081_20200330111413524_21321-5
  • ◆
    Independent Non-Executive DirectorExecutivesGlaxoSmithKline plc
    14,217 USD7FCA-NSM
    349.746 shares@ US$40.654.1% of flown/aISIN US37733W1053FCA-NSM:LSE20171025152118_13409025_20200330131538139_17441-5

17 of 17 declarations